A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...

Type of cancer has a notoriously low survival rate, with the NHS acknowledging that it "can be difficult to treat" ...

Pancreatic cancer is hard to detect at the early stages and is also hard to treat. However, health bodies say there are four ...

Pancreatic cancer is one of the most lethal forms of the disease and is known to be difficult to treat. However, there are ...

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...

Pifani has lost several family members to pancreatic cancer — including a cousin and uncle who both died in six months or less — so he feels “extremely fortunate.” The family has a genetic mutation ...

Pancreatic cancer, the ultimate master of disguise, often sneaks in without a grand entrance—until it is already made itself at home. From surprise weight loss to unexpected digestive drama, here are ...

Pancreatic neuroendocrine cancers are rare cancers. They start in the neuroendocrine cells of the pancreas. Your healthcare team might call them pancreatic neuroendocrine neoplasms, or pancreatic NENs ...

3.3 Pathways for the transdifferentiation of α-cell to β-cell Transdifferentiation of α-cells to β-cells is a key demonstration of endocrine cell plasticity within pancreatic islets, involving a ...

Pancreatic cancer remains one of the hardest cancers to detect early, but this study provides a new clue. If doctors can use gallstones as an early warning, they may diagnose pancreatic cancer sooner, ...